Tag: Buy
Canaccord Trims PagerDuty (MDB) Price Target, Maintains Buy Rating
PagerDuty, Inc. (NYSE:PD) is a prominent player in the AI stocks market, with Canaccord Genuity recently adjusting its…
Ambarella Shares Surged on News the Chipmaker Is Exploring a Sale. Should You Buy AMBA Stock Here?
Ambarella (AMBA) shares experienced a significant surge of nearly 20% on Tuesday after reports surfaced that the Santa…
3 Growth Stocks You Can Buy for Less Than $100 Right Now
The stock market offers a plethora of opportunities for investors, even for those who don't have a fortune…
Teladoc Stock Is a ‘Coiled Spring’ That Could Surge Higher. Should You Buy TDOC Here?
Teladoc (TDOC) shares have been on the rise after Citron Research released a report likening them to a…
Broadcom Just Got a New Street-High Price Target. Should You Buy AVGO Stock Here?
Broadcom (AVGO) shares surged by 5% on Tuesday following a bullish note from senior HSBC analyst, Frank Lee.…
Is AAPL Stock a Buy? Jim Cramer Says ‘Maybe Not’ Unless Apple Does This 1 Surprising Thing.
In a recent episode of the popular CNBC show "Mad Money," host Jim Cramer made a bold suggestion…
UK to buy fighter jets capable of carrying nuclear weapons
Britain has announced plans to purchase a dozen F-35A fighter jets capable of firing tactical nuclear weapons, marking…
Home Depot’s Dividend Strengthens as TD Cowen Reaffirms Buy Rating
The Home Depot, Inc. (NYSE:HD) is considered one of the best dividend stocks according to Jim Cramer, a…
Craig-Hallum Maintained a Buy Rating on Ambarella (AMBA), Keeps the PT
Ambarella, Inc. (NASDAQ:AMBA) is a prominent player in the tech industry and is considered one of the 11…
Why Barbara Corcoran Says Now Might Be the Best Time To Buy a House
The current state of the housing market can be quite overwhelming, with fluctuating mortgage rates and fierce competition…
Cathie Wood Thinks SpaceX Will Hit $2.5 TRILLION in 5 Years. You Can Buy This 1 ETF Now to Profit.
SpaceX, the aerospace company founded by Elon Musk, is poised for significant growth according to Cathie Wood's Ark…
Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push
Eli Lilly to Acquire Gene-Editing Startup Verve Therapeutics for $1.3 Billion By Christy Santhosh and Sriparna Roy In…